Cargando…
Liquid Jet Delivery Method Featuring S100A1 Gene Therapy in the Rodent Model Following Acute Myocardial Infarction
The S100A1 gene is a promising target enhancing contractility and survival post myocardial infarction (MI). Achieving sufficient gene delivery within safety limits is a major translational problem. This proof of concept study evaluates viral-mediated S100A1 overexpression featuring a novel liquid je...
Autores principales: | Fargnoli, Anthony S., Katz, Michael G., Williams, Richard D., Kendle, Andrew P., Steuerwald, Nury, Bridges, Charles R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4742412/ https://www.ncbi.nlm.nih.gov/pubmed/26461176 http://dx.doi.org/10.1038/gt.2015.100 |
Ejemplares similares
-
In Situ Heart Isolation Featuring Closed Loop Recirculation: The Gold Standard for Optimum Cardiac Gene Transfer?
por: Katz, Michael G, et al.
Publicado: (2017) -
Anti-inflammatory loaded poly-lactic glycolic acid nanoparticle formulations to enhance myocardial gene transfer: an in-vitro assessment of a drug/gene combination therapeutic approach for direct injection
por: Fargnoli, Anthony S, et al.
Publicado: (2014) -
Targeted Gene Delivery through the Respiratory System: Rationale for Intratracheal Gene Transfer
por: Katz, Michael G., et al.
Publicado: (2019) -
The Clinical Features of Myocardial Infarction
por: Gilchrist, A. R.
Publicado: (1930) -
S100A9 is a functional effector of infarct wall thinning after myocardial infarction
por: Chalise, Upendra, et al.
Publicado: (2022)